Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-20-005509
Filing Date
2020-03-31
Accepted
2020-03-31 17:29:46
Documents
64
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 87981
2 ex31.htm EX-31 6783
3 ex32.htm EX-32 5133
  Complete submission text file 0001493152-20-005509.txt   3524135

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE age-20191231.xml EX-101.INS 642485
5 XBRL SCHEMA FILE age-20191231.xsd EX-101.SCH 43814
6 XBRL CALCULATION FILE age-20191231_cal.xml EX-101.CAL 68194
7 XBRL DEFINITION FILE age-20191231_def.xml EX-101.DEF 215171
8 XBRL LABEL FILE age-20191231_lab.xml EX-101.LAB 354140
9 XBRL PRESENTATION FILE age-20191231_pre.xml EX-101.PRE 308058
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38519 | Film No.: 20762954
SIC: 2834 Pharmaceutical Preparations